NASDAQ: ASND
Ascendis Pharma A Stock Ownership - Who owns Ascendis Pharma A?

Insider buying vs selling

Have Ascendis Pharma A insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASND insiders and whales buy or sell their stock.

ASND Shareholders

What type of owners hold Ascendis Pharma A stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP16.83%10,281,496$2.06BInstitution
Westfield Capital Management Co LP8.61%5,259,909$1.05BInstitution
Avoro Capital Advisors LLC8.36%5,110,000$1.02BInstitution
Fmr LLC7.32%4,471,733$894.30MInstitution
Janus Henderson Group PLC7.08%4,323,059$864.57MInstitution
Lombard Odier Asset Management Europe Ltd6.99%4,269,000$853.76MInstitution
Artisan Partners Limited Partnership6.09%3,720,880$744.14MInstitution
Capital International Investors5.01%3,060,616$612.09MInstitution
T Rowe Price Investment Management Inc4.36%2,666,618$533.30MInstitution
Massachusetts Financial Services Co3.08%1,882,781$376.54MInstitution

1 of 3

ASND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASND100.00%0.00%
EXEL93.47%5.23%Net SellingNet Selling
BMRN93.36%1.73%Net SellingNet Selling
IONS97.00%3.00%Net SellingNet Selling
MRNA70.28%22.74%Net BuyingNet Buying

Ascendis Pharma A Stock Ownership FAQ

Who owns Ascendis Pharma A?

Ascendis Pharma A (NASDAQ: ASND) is owned by 112.06% institutional shareholders, 0.00% Ascendis Pharma A insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Ascendis Pharma A shareholder, owning 10.28M shares representing 16.83% of the company. Ra Capital Management LP's Ascendis Pharma A shares are currently valued at $2.06B.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.